Company: BridGene Biosciences Inc.
Job title: Director - Biology
A Covalent TEAD Inhibitor with Exceptional Anti-cancer Activity & Combination Potential 2:15 pm
Presenting preclinical updates on a lead covalent TEADi including in vivo efficacy Harnessing TEAD selectivity to expand into TEADi-responsive indications Exploring combination approaches with KRASiRead more
day: Conference Day One